Nederlands
English
About VIB
Currently selected
Science communication
Home
>
About VIB
>
Press
Refine
Theme
About VIB (92)
Arabidopsis (3)
Bioinformatics (11)
Biotech basics (1)
Cancer (69)
Cardiovascular medicine (11)
Cell biology (9)
Grand Challenges (4)
Immunology (32)
Inflammation and immunity (53)
Microbiology (21)
Model Organisms (4)
Mouse (2)
Neuroscience (58)
Plant biology (41)
Proteomics (5)
Research Areas (3)
Science ethics (2)
Structural biology (17)
Systems biology (2)
Yeast (1)
Category
BioInformatics Training and Service facility (1)
Business opportunities (8)
Developmental biology (1)
Event (8)
News (34)
Research services (5)
Page Content Zone 1
Press
Receive VIB press releases
Email updates
Follow us on Twitter
Like us on Facebook
RSS
Contact
For all press inquiries, contact
VIB
Tel.: +32 9 244 66 11
info@vib.be
Recent press releases
Steroid synthesis discovery could rewrite the textbooks
26 November 2018
Researchers from the VIB-UGent Center for Plant Systems Biology, the University of Technology Sydney Climate Change Cluster & the University of Queensland have discovered a new central enzyme in the steroid biosynthesis pathway in some modern organisms
Revolutionary molecular diagnostic cancer test
24 November 2018
Biocartis launched a fast, accurate msi assay on its idylla™ platform, offering the Potential to predict effective cancer treatment options.
Better understanding of hydrogen peroxide (H2O2) regulation can lead to new insights into disease development
22 November 2018
The team of Joris Messens at the VIB-VUB Center for Structural Biology provided new insights into the regulation of an important intracellular messenger molecule whose dysregulation has been linked to the development of several diseases, including cancer.
Scientists shed new light on infection process of the gastrointestinal pathogen C. difficile
21 November 2018
Scientists from the VIB-UGent Center for Inflammation Research identified mechanisms by which the bacterial pathogen Clostridium difficile kills intestinal epithelial cells (IECs), thus destroying the protective mucosal barrier of the intestinal tract
How your moving brain sees the world
20 November 2018
In a new study, scientists from NERF (Neuro-Electronics Research Flanders) uncover that the processing of visual information in the brain is indeed modulated by our own behavior.
Identification of LZTR1 leads to novel insights into RAS-driven diseases
16 November 2018
Michail Steklov, Francesca Baietti, and colleagues from the Anna Sablina lab (VIB-KU Leuven Center for Cancer Biology) identified LZTR1 as an evolutionarily conserved component of the RAS pathway.
Patchy distribution of joint inflammation resolved
15 November 2018
Chronic inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and spondylo-arthritis (SpA) are chronic disabling diseases that have a poor outcome on loco-motoric function, if left untreated. RA en SpA affect each about 1% of the population.
Researchers discover novel “to divide or to differentiate” switch in plants
14 November 2018
Scientists from VIB and Ghent University under the guidance of Prof. Dr. Jenny Russinova uncovered a novel mechanism in plants that controls an important decision step in stomatal lineage to divide asymmetrically or to differentiate.
VIB accelerates therapeutic biologics discovery with geneious biologics
12 November 2018
Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been chosen by VIB to support therapeutic biologics discovery at its Discovery Sciences group.
Belgian beer landscape mapped using scientific insights
12 November 2018
Miguel Roncoroni and Kevin Verstrepen (VIB-KU Leuven Center for Microbiology) have published the very first scientific beer atlas that explains how each beer relates to other beers on the basis of a unique dataset.
Marc Van Montagu celebrates 85th birthday
10 November 2018
Today we celebrate the 85th birthday of Em. Prof. Marc Van Montagu, one of VIB’s founding fathers. Marc was born on November 10, 1933 in Ghent. This week, on November 5, 2018, Marc received an honorary doctorate from the Weizmann Institute in Israel.
BioLegend partners on TotalSeqTM antibodies to boost single cell surface protein profiling within VIB
31 October 2018
BioLegend, a world-class antibody provider, announced today a new partnership with VIB to evaluate and implement the TotalSeqTM antibodies for next-generation multi-omics by the combining single cell transcriptomics with single cell proteomics profiling.
Neuroscientists build a tool to “read the mind” in real-time
30 October 2018
Understanding how we learn & remember means measuring and decoding the activity patterns of complex circuits in our brain. Researchers at NERF (NeuroElectronics Research Flanders) developed a new method to measure and interpret brain activity in real-time
Insights into melanoma initiation offer new therapeutic opportunities
29 October 2018
Researchers from VIB and KU Leuven uncovered a key vulnerability of melanoma. While studying the role of the melanoma-specific long non-coding RNA SAMMSON in tumor initiation, they found that it boosts protein synthesis in different cellular compartments.
A protective role for progranulin in frontotemporal dementia and ALS
26 October 2018
In a recent study in Molecular Neurodegeneration, researchers from VIB-KU Leuven led by prof. Philip Van Damme, reveal neuroprotective effects of progranulin against TDP-43 accumulation and neurodegeneration.
«Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
Next»
Page Content Zone 2
Page Content Zone 3